Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
about
Therapeutic antibodies, vaccines and antibodyomesThe important molecular markers on chromosome 17 and their clinical impact in breast cancerNovel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice.Therapeutic antibodies against cancer.A Network-Based Model of Oncogenic Collaboration for Prediction of Drug Sensitivity.Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer.Cancer Immunotherapy Using γδT Cells: Dealing with Diversity.Helping Eve overcome ADAM: G-quadruplexes in the ADAM-15 promoter as new molecular targets for breast cancer therapeutics.Structure-based and ligand-based drug design for HER 2 receptor.Endocrine mucin-producing sweat gland carcinoma: a study of three cases and CK8, CK18 and CD5/6 immunoexpression.
P2860
Q24599662-6A02A0A3-1694-44A8-8877-9BA74918DA0FQ26859002-AC2ABB6B-97A5-4058-B04A-E00D53302848Q31039304-3C9FE496-A2D8-4D52-91D7-ABE8CD81EEC2Q35908498-2B03BA77-D533-4EE1-9DB9-AEB3CE60A412Q36396515-110876FB-BA90-4568-B8B2-29A106FAF45FQ37360194-50D5E388-0188-40A4-A852-85E81CEE9134Q38283536-0B3D807B-9D16-47E3-AFC2-7A1FEAEC5601Q39045519-8C10ED48-BBFA-4EF6-81B7-240868451FCBQ43061745-C2594953-4C0E-4144-9D9E-D95C25E76A5BQ46934882-54F0FD2D-97C2-4AFE-AA11-D97B513FC692
P2860
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@en
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@nl
type
label
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@en
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@nl
prefLabel
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@en
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@nl
P356
P1476
Current paradigms for the use of HER2-targeted therapy in early-stage breast cancer.
@en
P304
P356
10.3816/CBC.2008.S.012
P407
P478
P577
2008-12-01T00:00:00Z